The main aim of this study was to determine the potential bioaccessibility of bearberry phytochemicals influenced by the type of herbal preparations. Herbal preparations-powdered plant materials and dry extracts obtained using various ethanol concentrations (0%, 20%, 40%, 60%, 80%, and 100%) were subjected to simulated gastric or gastrointestinal digestion for the evaluation of the bioaccessibility of the phytochemicals. The phytochemical characterization of the plant material, dry extracts, and potentially bioaccessible fractions was performed using high-performance liquid chromatography (HPLC) and spectrophotometric assays. The content of the main compounds, i.e., arbutin, hydroquinone, hyperoside, pentagalloylglucose, and picein, as well as the total phenolic content and in vitro antioxidant activity through the ABTS-scavenging activity and Fe-reducing power were determined. The bioaccessibility of arbutin, i.e., the main compound in bearberry, was high, in most cases exceeding 95%, and was generally unaffected by the experimental factors; however, the changes in the content of the other compounds, the total phenolic content, and the antioxidant activity were more prominent and influenced by the type of the herbal preparation and the stage of digestion. Given the compromise between the abundance of the bearberry phytochemicals, the antioxidant activity, and the resulting potential bioaccessibility of these phytochemicals, the dry extracts prepared with 40% ethanol seem to be the most promising for phytopharmaceutical purposes and functional food applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11678513 | PMC |
http://dx.doi.org/10.3390/molecules29245968 | DOI Listing |
Nat Prod Res
January 2025
School of Biological Science and Technology, University of Jinan, Jinan, China.
Five previously unreported 5-hydroxymethylfurfural (5-HMF) derivatives, including chinenfurfurals A () and B () as 5-HMF-citric acid hybrids and chinenfurfurals C-E (-) as 5-HMF oligomers, as well as four known analogues (-), were isolated from the fruits of a well-known Chinese herbal species . The structures of these furfural compounds were established by detailed analyses of spectroscopic data especially HRMS and NMR, and it is the first report of furfural type constituents from the title species. The anti-inflammatory property of them was further evaluated by testing their inhibition against the production of nitric oxide in lipopolysaccharide-activated murine RAW264.
View Article and Find Full Text PDFSci Rep
January 2025
Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, No.199 Donggang West Road, 730000, Gansu Province, China.
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors, and lack of human epidermal growth factor receptor 2 (HER2) expression. Traditional Chinese medicine (TCM) has demonstrated promising efficacy in treating TNBC. This study explored the mechanisms of pachymic acid (PA) on TNBC by merging network pharmacology with experimental validation.
View Article and Find Full Text PDFInt Immunopharmacol
January 2025
Allergen-reactive T helper (Th) 2 cells play a pivotal role in initiating asthma pathogenesis. The absence or interruption of CD28 signaling causes significant consequences for T-cell activation, leading to reduced cell proliferation and interleukin (IL)-2 production. A novel compound, Cyn-1324, exhibits a higher binding affinity to CD28 than CD80.
View Article and Find Full Text PDFDrug Des Devel Ther
January 2025
Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, People's Republic of China.
Background: Dachaihu decoction (DCHD) is a common Chinese medicine formula against sepsis-induced acute lung injury (SALI). PANoptosis is a novel type of programmed cell death. Nevertheless, The mechanisms of DCHD against SALI via anti-PANoptosis remains unknown.
View Article and Find Full Text PDFDrug Des Devel Ther
January 2025
Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory, Beijing, 100079, People's Republic of China.
Purpose: This study aims to explore the mechanism of Yangxuerongjin pill (YXRJP) in the treatment of diabetic peripheral neuropathy (DPN) by network pharmacology and metabolomics technology combined with animal experiments, and to provide scientific basis for the treatment of DPN.
Methods: In this study, network pharmacology analysis was applied to identify the active compounds, core targets and signal pathways, which might be responsible for the effect of DPN. The DPN model was established by high-fat diet combined with streptozotocin (STZ) injection, and the rats were given administration for 12 weeks.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!